RARE

ULTRAGENYX PHARMACEUTICAL INC

Healthcare | Mid Cap

-$1.31

EPS Forecast

$186.2

Revenue Forecast

Announcing earnings for the quarter ending 2025-12-31T00:00:00 soon
ALKSAlkermes PlcNKTRNektar TherapeuticsBMRNBiomarin Pharmaceutical IncIONSIonis Pharmaceuticals IncSRPTSarepta Therapeutics IncALNYAlnylam Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcSAGESage Therapeutics IncPAHCPhibro Animal Health Corp